XML 29 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Condensed Statements Of Cash Flows (USD $)
In Thousands
6 Months Ended
Jul. 31, 2011
Jul. 31, 2010
Cash flows from operating activities:    
Net income including noncontrolling interests $ 7,589 $ 6,699
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,519 7,646
Impairment charges and other 1,153 510
Income from equity method investments (9,543) (3,930)
Income from synthetic fuel investments (2,883)  
(Gain) loss on disposal of real estate and property and equipment (271) 28
Dividends received from equity method investees 2,316 802
Deferred income (2,367) (4,422)
Derivative financial instruments (608) 335
Deferred income tax 2,859 1,375
Changes in assets and liabilities:    
Accounts receivable 1,738 231
Inventory (2,551) 2,326
Other assets 9,890 7,412
Accounts payable, trade (1,652) (869)
Other liabilities 1,665 (2,154)
Net cash provided by operating activities 12,854 15,989
Cash flows from investing activities:    
Capital expenditures (637) (918)
Proceeds from sale of synthetic fuel investment 2,883  
Purchase of equity method investment   (9,216)
Principal payments received on investment in debt instruments   933
Proceeds from sale of real estate and property and equipment 1,603 1,540
Restricted investments   500
Net cash provided by (used in) investing activities 3,849 (7,161)
Cash flows from financing activities:    
Payments of long-term debt and capital lease obligations (5,136) (17,737)
Repayments of contingent consideration (1,313)  
Stock options exercised 312 1,438
Payments to noncontrolling interests holders (1,796)  
Other (192)  
Treasury stock acquired (3,162) (3,311)
Net cash used in financing activities (11,287) (19,610)
Net increase (decrease) in cash and cash equivalents 5,416 (10,782)
Cash and cash equivalents, beginning of period 91,019 100,398
Cash and cash equivalents, end of period 96,435 89,616
Non cash activities - Accrued capital expenditures $ 440 $ 102